About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Philadelphia | 157 Studies

Clinical Trials Alzheimer's DiseasePhiladelphia

Alzheimer's Disease Clinical Trials in Philadelphia

Find 157 clinical trials for alzheimer's disease near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 157 trials

CompletedStudy Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's DiseaseThis is a study to evaluate the safety of multiple doses of AAB-003 (PF-05236812) in patients with mild to moderate Alzheimer's Disease.NCT01193608·Escondido, California and 28 others CompletedThe Healthy Patterns Sleep StudyThe Healthy Patterns Study intervention is a home-based activity intervention designed to improve symptoms of circadian rhythm disorders (CRD) and quality of life (QOL) in…NCT03682185·Philadelphia, Pennsylvania

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

Enrolling by invitationThe Diabetes Prevention Program Outcomes Study AD/ADRD ProjectThe DPPOS AD/ADRD project will address the overarching question: What are the determinants and the nature of cognitive impairment among persons with pre-diabetes (PreD) and type 2…NCT05704309·Phoenix, Arizona and 26 others

CompletedEfficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)The primary objective is to evaluate the efficacy of T-817MA as measured by ADAS-cog and ADCS-CGIC.NCT02079909·Phoenix, Arizona and 49 others

CompletedRisk Evaluation and Education for Alzheimer's Disease (REVEAL) IVThis study is intended to examine the impact of receiving a genetic risk assessment for Alzheimer's disease (AD) among individuals with Mild Cognitive Impairment (MCI).NCT01434667·Washington D.C., District of Columbia and 2 others

CompletedEffects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's DiseaseThe purposes of this study are to determine: * The safety of LY450139 dihydrate and any side effects that might be associated with it.NCT00244322·La Jolla, California and 5 others

CompletedAnalysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD SubjectsA Phase 2/3 cross-sectional and longitudinal observational study evaluating imaging characteristics of flortaucipir in control subjects and patients with clinically defined MCI…NCT02016560·Phoenix, Arizona and 26 others

CompletedA Family-centered Intervention for Acutely-ill Persons With DementiaThis study will address the effectiveness of Family-centered Function Focused Care (Fam-FFC).NCT03046121·Lancaster, Pennsylvania and 2 others

Enrolling by invitationAlzheimer's Disease Neuroimaging Initiative 4The Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4) is a non-randomized, longitudinal, natural history study designed to validate biomarkers, improve clinical trial design…NCT05617014·Birmingham, Alabama and 64 others

CompletedA Study of Mevidalen (LY3154207) in Participants With Alzheimer's DiseaseThe main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer…NCT06538116·Phoenix, Arizona and 63 others

CompletedRosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's DiseaseRosiglitazone (RSG) has been tested in clinical studies and is approved by the FDA as a treatment for type II diabetes mellitus, a disease that occurs when the body is unable to…NCT00348140·Sun City, Arizona and 193 others

CompletedEvaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's DiseaseThis study will evaluate whether visual interpretation of flortaucipir-PET (positron emission tomography) scans, examining patterns of tracer uptake at baseline, can predict the…NCT03901105·Philadelphia, Pennsylvania

CompletedSafety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)The purpose of this study is to evaluate the long-term safety of AVP-923 in the treatment of Involuntary Emotional Expression Disorder (IEED) also known as Pseudobulbar Affect…NCT00056524·Phoenix, Arizona and 38 others

CompletedTo Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's PatientsThis study will investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients.NCT01023685·Costa Mesa, California and 7 others

CompletedArterial Spin Labeling (ASL) MRI for Cognitive DeclineThe purpose of this study is to determine the value of Arterial Spin Labeling (ASL) MRI, a measure of blood flow to the brain, in Mild Cognitive Impairment (MCI) and compare it to…NCT01727622·Philadelphia, Pennsylvania

CompletedSafety and Efficacy of Tafamidis in Patients With Transthyretin CardiomyopathyThis Phase 3 study will investigate the efficacy, safety and tolerability of an oral daily dose of 20 mg or 80 mg tafamidis meglumine capsules compared to placebo in subjects with…NCT01994889·Birmingham, Alabama and 79 others

CompletedSafety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's PatientsThis study will evaluate the safety and tolerability of repeated subcutaneous injections of CAD106 in patients with mid Alzheimer's diseaseNCT00795418·Costa Mesa, California and 9 others

CompletedStudy Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's DiseaseThe purpose of the study is to determine the safety, tolerability, and efficacy of 3 doses of lecozotan in combination with a cholinesterase inhibitor in patients with mild to…NCT00277810·Phoenix, Arizona and 82 others

CompletedStudy to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's DiseaseThe purpose of the study is to evaluate safety and the pharmacodynamic effects of BMS-241027 on cerebrospinal fluid (CSF) Tau, connectivity magnetic resonance imaging (MRI), and…NCT01492374·Anaheim, California and 23 others

CompletedCATIE-Alzheimer's Disease TrialThe CATIE Alzheimer's Disease Trial is part of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project.NCT00015548·Tuscaloosa, Alabama and 33 others

PreviousPage 4 of 8Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia